PharmaMar’s capital set at €10.8 million after reduction, divided into 18 million shares with unit value of €0.60
Link Securities | PharmaMar (PHM) informed the National Securities Market Commission that, in relation to the execution of the capital reduction through the redemption of treasury shares announced on 30 July 2025, the deed of capital reduction (and consequent amendment to the articles of association) of PHM for an amount of €133,336.80 through the redemption of 222,228 treasury shares with a par value of €0.60 each has been registered in…